Formic Acid

Formic Acid

SCHEMBL3752030

CN1CCN(C(C(=O)NNc2cc(Cl)cc(Cl)c2)c2cccc3c2oc2ccccc23)CC1.O=CO

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.51
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
CCR3 P51677 3/20 0.34
ABCB1 P08183 3/20 0.34
TP53 P04637 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTR2C P28335 1/20 0.33
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3639283 0.96 GHSR (0.55) GHSRALDH1A1LMNAPOLBSMN1; SMN2
Formic Acid SCHEMBL3636056 0.86 GHSR (0.55) GHSRALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL3741629 0.82 GHSR (0.59) GHSRALDH1A1LMNAPOLBSMN1; SMN2
Formic Acid SCHEMBL3636188 0.82 GHSR (0.51) GHSRALDH1A1LMNAPOLBSMN1; SMN2
Formic Acid SCHEMBL3740718 0.81 GHSR (0.48) GHSRALDH1A1LMNAKDM4ECCR3
SCHEMBL3639373 0.80 GHSR (0.76) GHSRALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL3639671 0.78 GHSR (0.58) GHSRALDH1A1LMNAPOLBMAPT
SCHEMBL13078722 0.78 GHSR (0.54) GHSRALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL13044324 0.77 MC4R (0.40) ALDH1A1LMNASMN1; SMN2KDM4EMAPT
SCHEMBL3636661 0.77 GHSR (0.52) GHSRALDH1A1LMNAKDM4ECCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US claimed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R GHSR 2/4885ALDH1A1 2645/4885LMNA 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.